0
Article |

Hemorrhagic Cystitis Following Accidental Overdose of Methenamine Mandelate FREE

Robert R. Ross, MD; Gerald F. Conway, MD
[+] Author Affiliations

Received for publication June 23, 1969.

Reprint requests to the Department of Urology, Wayne State University School of Medicine, 1400 Chrysler Freeway, Detroit 48207 (Dr. Ross).


Am J Dis Child. 1970;119(1):86-87. doi:10.1001/archpedi.1970.02100050088021.
Text Size: A A A
Published online

Hemorrhagic cystitis may be caused by a variety of inciting agents. Chemical cystitis associated with drug therapy is recognized. These drugs are primarily of the antimetabolite class utilized in chemotherapy of neoplasms. Methenamine mandelate has been widely used as a safe and relatively effective urinary antibacterial agent. In the urine, it breaks down to methenamine and mandelic acid. Both of these are active compounds in that they both have mild antibacterial effect. Methenamine, in acid pH, releases ammonia and formic acid. Goodman and Gillman1 state that "Methenamine is of special value in patients suffering from renal insufficiency because the drug is nontoxic even if excretion is delayed. Untoward reactions are uncommon. On occasion, the patient may exhibit skin rashes or gastrointestinal upset." We have recently seen a child who exhibited gross hematuria and lower urinary tract irritative symptoms following accidental ingestion of a large amount of methenamine mandelate. Clinical,

REFERENCES

Goodman, L.S., and Gillman, A. (eds.): The Pharmalogical Basis of Therapeutics , ed 3, New York: Macmillan Co., 1965;, p 1030.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Goodman, L.S., and Gillman, A. (eds.): The Pharmalogical Basis of Therapeutics , ed 3, New York: Macmillan Co., 1965;, p 1030.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.